| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |